drug safety

sarepta building
Favicon Fierce Pharma

FDA backtracks on Sarepta's gene therapy Elevidys in DMD

The agency said that it had concluded that the death of an 8-year-old was not related to Elevidys but addressed none of the three prior deaths.
Angus Liu Jul 28, 2025 6:02pm
FDA
Favicon Fierce Pharma

FDA eyeing study requirements to confirm Elevidys safety: report

Jul 24, 2025 3:12pm
Sarepta Sarepta Therapeutics
Favicon Fierce Pharma

Sarepta will continue shipping Elevidys despite FDA misgivings

Jul 21, 2025 10:42am
Sarepta Sarepta Therapeutics

Sarepta faces new scrutiny after 3rd patient death

Jul 18, 2025 10:19am
A doctor with a graphic representation of the lungs

Pliant ends lung disease program over rise in adverse events

Jun 30, 2025 4:49am
FDA
Favicon Fierce Pharma

FDA investigates 2 deaths after Sarepta Duchenne gene therapy

Jun 25, 2025 10:26am